LNCARSR and neoplasm: Consistent with our study, several other studies had reported that lncRNAs promote tumor angiogenesis or sunitinib resistance in RCC, including HOTAIR and lncARSR [28, 29], supporting that lncRNAs may provide new targets for therapy and predictive biomarkers for anti-angiogenesis therapy response in RCC.